The efforts of government agencies and product marketers to convince Europeans of the importance of better oral care appears to have paid off as sales of oral care products jumped more than 6% in 2006.
LX1031 Investigational Drug Treats Irritable Bowel Syndrome
Lexicon Pharmaceuticals described the structure-activity relationship of LX1031 as potential treatments for irritable bowel syndrome.
Medicaid Panel Members Required To Disclose Ties To Pharmaceutical Companies
A Minnesota law requires pharmaceutical companies to report certain payments to physicians.
How People React To Direct-To-Consumer Drug Ads
FDA plans to study whether positive images featured in direct-to-consumer television advertisements for medications.
Drugs impair self-control in addicts
Drug addicts find it hard to exercise self-control because part of their brain does not function effectively.
Eli Lilly Program To Help States Monitor Psychiatric Prescriptions Examined
Eli Lilly program has helped Medicaid programs in Minnesota and other states monitor prescriptions for psychiatric medications
Seniors With Drug Coverage Significantly Increased Under Medicare Part D
Medicare prescription drug benefit has significantly increased the share of seniors with drug coverage, but one in five beneficiaries reported delaying or not filling prescriptions because of cost.
Watson Receives FDA Approval For Generic Duragesic
Watson Pharmaceuticals has received final approval from FDA on its Abbreviated New Drug Application for fentanyl transdermal system.
Optimal Drug Dose Of Common Anticoagulant
Genetic testing can be used to help personalize the therapeutic dosage of warfarin, a commonly-used anticoagulant.
FDA Rejects More New Medications This Year Than In 2006
FDA in recent months has rejected a slew of new drug applications or delayed approval of experimental medications and required more data.
Archives
1. ABBOTT TO REDUCE COST OF ANTIRETROVIRAL KALETRA BY 30 2. AS TEMPERATURES HEAT UP BEWARE OF HEAT RELATED ILLNESSES
3. BETTER BRUSHING HABITS BOOST EUROPEAN ORAL CARE SALES
4. DRUGS IMPAIR SELF CONTROL IN ADDICTS
5. DSHS ISSUES FLOOD RELATED HEALTH PRECAUTIONS
6. ELI LILLY PROGRAM TO HELP STATES MONITOR PSYCHIATRIC PRESCRIPTIONS EXAMINED
7. FDA APPROVES FIRST GENERIC VERSIONS OF LAMISIL TABLETS
8. FDA APPROVES MARKET GENERIC VERSION OF PAXIL
9. FDA REJECTS MORE NEW MEDICATIONS THIS YEAR THAN IN 2006
10. HAWAII CONSUMERS WARNED ABOUT COLGATE TOOTHPASTE
11. HEALTH AND SAFETY RECOMMENDATIONS IN RESPONSE TO FLOODING
12. HOW PEOPLE REACT TO DIRECT TO CONSUMER DRUG ADS
13. ILINOIS DEPARTMENT OF HEALTH ENCOURAGES SAFE FOOD HANDLING SWIMMING SAFETY WEST NILE VIRUS PREV
14. LX1031 INVESTIGATIONAL DRUG TREATS IRRITABLE BOWEL SYNDROME
15. MEDICAID PANEL MEMBERS REQUIRED TO DISCLOSE TIES TO PHARMACEUTICAL COMPANIES
16. OPTIMAL DRUG DOSE OF COMMON ANTICOAGULANT
17. OUTDOOR INJURY PREVENTION STARTS IN YOUR OWN BACK YARD
18. SENIORS WITH DRUG COVERAGE SIGNIFICANTLY INCREASED UNDER MEDICARE PART D
19. SUPERGEN REPORTS DOSING OF FIRST PATIENT IN PHASE I TRIAL OF NOVEL TYROSINE KINASE INHIBITOR
20. WATSON RECEIVES FDA APPROVAL FOR GENERIC DURAGESIC